NM_000245.4(MET):c.107A>G (p.Asn36Ser) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 14, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001768265.2

Allele description [Variation Report for NM_000245.4(MET):c.107A>G (p.Asn36Ser)]

NM_000245.4(MET):c.107A>G (p.Asn36Ser)

Gene:

MET:MET proto-oncogene, receptor tyrosine kinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7q31.2

Genomic location:

Preferred name:

NM_000245.4(MET):c.107A>G (p.Asn36Ser)

HGVS:

NC_000007.14:g.116699191A>G
NG_008996.1:g.31787A>G
NM_000245.4:c.107A>GMANE SELECT
NM_001127500.3:c.107A>G
NM_001324401.3:c.107A>G
NM_001324402.2:c.-91+26614A>G
NP_000236.2:p.Asn36Ser
NP_001120972.1:p.Asn36Ser
NP_001311330.1:p.Asn36Ser
LRG_662t1:c.107A>G
LRG_662:g.31787A>G
NC_000007.13:g.116339245A>G
NM_001127500.1:c.107A>G

Protein change:

N36S

Links:

dbSNP: rs1282716584

NCBI 1000 Genomes Browser:

rs1282716584

Molecular consequence:

NM_001324402.2:c.-91+26614A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_000245.4:c.107A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001127500.3:c.107A>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001324401.3:c.107A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided; RECLASSIFIED - ADRA2C POLYMORPHISM; RECLASSIFIED - ADRB1 POLYMORPHISM
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002008779	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (Jan 14, 2020)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002008779

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(Jan 14, 2020)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV002008779.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 16, 2025

ClinVar

Relating variation to medicine